| Literature DB >> 26991106 |
Andrea Bedoya-López1, Karel Estrada2, Alejandro Sanchez-Flores2, Octavio T Ramírez3, Claudia Altamirano4, Lorenzo Segovia5, Juan Miranda-Ríos1, Mauricio A Trujillo-Roldán1, Norma A Valdez-Cruz1.
Abstract
Recombinant proteins are widely used as biopharmaceuticals, but their production by mammalian cell culture is expensive. Hence, improvement of bioprocess productivity is greatly needed. A temperature downshift (TDS) from 37°C to 28-34°C is an effective strategy to expand the productive life period of cells and increase their productivity (qp). Here, TDS in Chinese hamster ovary (CHO) cell cultures, initially grown at 37°C and switched to 30°C during the exponential growth phase, resulted in a 1.6-fold increase in the qp of recombinant human tissue plasminogen activator (rh-tPA). The transcriptomic response using next-generation sequencing (NGS) was assessed to characterize the cellular behavior associated with TDS. A total of 416 (q > 0.8) and 3,472 (q > 0.9) differentially expressed transcripts, with more than a 1.6-fold change at 24 and 48 h post TDS, respectively, were observed in cultures with TDS compared to those at constant 37°C. In agreement with the extended cell survival resulting from TDS, transcripts related to cell growth arrest that controlled cell proliferation without the activation of the DNA damage response, were differentially expressed. Most upregulated genes were related to energy metabolism in mitochondria, mitochondrial biogenesis, central metabolism, and avoidance of apoptotic cell death. The gene coding for rh-tPA was not differentially expressed, but fluctuations were detected in the transcripts encoding proteins involved in the secretory machinery, particularly in glycosylation. Through NGS the dynamic processes caused by TDS were assessed in this biological system.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26991106 PMCID: PMC4798216 DOI: 10.1371/journal.pone.0151529
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
List of primer sequences used for verification of differentially expressed genes determined by NGS.
| PrimerGen ID | Forward (5′-3′) | Reverse (5′-3′) | Amplicon (bp) |
|---|---|---|---|
| ATGACAGGCACTTGAAGACC | CCCCGGGATCTTTGAGTCTC | 90 | |
| AGTGAGCACCTTGTCCCCAC | AAAGTCTGGTCACGAGGCCA | 91 | |
| GTCCTAGGGGAGCATGGAGA | TTGTCGGTATCAGTGCCCAG | 107 | |
| GAGGAAGGAAATTGCAGGGC | GGCTCTATGTCGGAAGATTT | 91 | |
| GTTGGCCCTGTTCCAGTGTT | GCAGCCAAATCTATGAGC GT | 100 | |
| TGGTGAATGATGGGGTGGAA | GGCAGGGCCTTCACATAGTC | 97 | |
| AGCTGAGAGGGAAATTGTGCG | AGGAAGAGGATGCAGCAGTG | 95 | |
| CAAGACGGATGAGCATGCAG | CACCTCCTCAGCTTGCCACT | 91 | |
| GAGGCTTGCCCCTGAGTATG | GGTGTTTGTGTTGGCAGTGC | 91 | |
| AGAAGGTGGTGAAGCAGGCAT | CAAAGGTGGAAGAGTGGGAGTC | 87 |
Fig 1Kinetics of cell growth and rh-tPA production.
Recombinant CHO TF70R viable cell density (A), percentage of cell viability (B), rh-tPA production (C), cell-specific rh-tPA production (D), glucose consumption (E), lactate production (F), and glutamine consumption (G) of cell cultures at 37°C (closed squares), and under temperature downshift (TDS) to 30°C at 48 h (open circles). Dotted line denotes TDS from 37 to 30°C, and transcriptomic samples were taken at 24 and 48 h after TDS.
Kinetic and stoichiometric parameters of CHO cells in the biphasic and control cultures.
| μ (h-1) | 0.021 ± 0.02 | 0.005 ± 0.001 |
| Xmax (106 cell/ml) | 2.70 ± 0.15 | 2.67 ± 0.10 |
| Cell viability (%) | 87.60 ± 1.50 | 89.60 ± 2.00 |
| Ylac/glc (mol/mol) | 0.85 ± 0.01 | 0.69 ± 0.02 |
| 0.53 ± 0.02 | 0.82 ± 0.03 | |
| rh-tPA max (mg/L) | 4.60 ± 1.20 | 11.15 ± 0.40 |
| 26.9 ± 0.81 | 25.9 ± 1.24 | |
| 112 ± 1.67 | 98.4 ± 3.54 | |
| 160 ± 1.23 | 130 ± 7.32 |
*The specific growth rate (μ) was calculated for the first 4 days in those cultures carried out at 37°C; for biphasic cultures, μ was calculated for the 4 days after temperature downshift.
aBiphasic culture data with statistically significant differences (Student’s t-test with a significance level of p < 0.05) from the control culture (37°C) data.
Fig 2Transcript abundance analysis of 21,789 genes after temperature downshift (TDS).
Differential expression determined by Illumina sequencing of duplicated samples collected at 24 h (A) and 48 h (B) after TDS of culture and compared to the control culture at 37°C, sampled at 48 h of culture (bioinformatic analysis in Materials and Methods). Coding DNA sequence data in each condition were analyzed with the non-parametric and data-adaptive algorithm NOISeq R package [29], following TMM normalization. Genes without differential expression are represented by light gray dots. Genes with differential expression (>1.6 fold change) are shown in dark gray with q of 0.6–0.8 (A), and q of 0.9–0.95 (B). Those that are differentially expressed (>1.6 fold change) with q > 0.8 (A) and q > 0.95 (B) are shown in black dots.
Fig 3Enriched gene ontology annotation of differentially expressed genes.
In total, 171 genes at 24 h after TDS (>1.6 fold change, q > 0.8) and 995 genes at 48 h after TDS (>1.6 fold change, q > 0.95) were classified in sub-ontologies. Enrichment scores on the y-axis and x-axis bar charts represent the follows: GO type—A, Biological process; B, Cellular component; and C, Molecular function. (CPM) cellular protein modulation, (SGTP ST) small GTPase signal transduction, (MBM) microtubule-based movement, (R GTP ST) regulation of GTPase signal transduction, (APP) antigen process and presentation, (R RGT PA) regulation of Rab GTPase activity, (CSD) chromatin assembly or disassembly, (CD PS) cyclin-dependent protein serin.
Comparison of fold-changes in differentially expressed genes determined by NGS and by RT-PCR.
| Gene | Fold change NGS 48 h after TDS (q) | Fold change real time PCR 48 h after TDS |
|---|---|---|
| 13.54 (0.99) | 14.01 ± 0.55 | |
| 7.76 (0.99) | 7.38 ± 0.28 | |
| 1.13 (0.34) | 1.08 ± 0.08 | |
| 2.27 (0.92) | 1.57 ± 0.23 | |
| 3.15 (0.95) | 2.38 ± 0.18 | |
| 1.12 (0.54) | 1.01 ± 0.02 | |
| 1.44 (0.72) | 1.48 ± 0.16 | |
| 3.78 (0.93) | 4.42 ± 0.06 |
aBiphasic culture data with statistically significant differences from that of the control culture (37°C).
Comparison of the fold change of highlighted differentially expressed of genes affected by the TDS response.
Differentially expressed transcripts (> 1.6 fold) with respect to the control q > 0.8 at 24 hour and q > 0.95 at 48 hour after TDS are indicated in bold lettering. Gene descriptions and putative functions were obtained from www.genecards.org.
| Gene | Gene description | Putative function | Fold change NGS, 24 h after TDS (q) | Fold change NGS, 48 h after TDS (q) |
|---|---|---|---|---|
| RNA Binding Motif Protein 3 | Cold-inducible mRNA binding protein, enhances protein synthesis at mild hypothermic temperatures | |||
| Cold Inducible RNA Binding Protein | Protective role by stabilizing transcripts of genes involved in cell survival. | |||
| Vimentin | Intermediate filament protein attached to the nucleus, ER, and mitochondria | 1.47 (0.50) | 2.37 (0.93) | |
| Transient Receptor Potential Cation Channel, Subfamily V, Member 3 | It is activated by innocuous (warm) temperatures | -1.5 (0.07) | 1.00 (0.22) | |
| Dihydrofolate Reductase | Catalyzes an essential reaction for de novo glycine and purine synthesis | 1.14 (0.23) | -1.08 (0.40) | |
| Plasminogen Activator Tissue | Recombinant gene | 1.03 (0.09) | 1.13 (0.34) | |
| Serine/threonine protein kinase | Important cell cycle checkpoint kinase, regulator of a wide variety of downstream proteins | -2.16 (0.69) | ||
| Serine/Threonine-Protein Kinase | Related to ATM, cell cycle checkpoint gene required for cell cycle arrest | -1.72 (0.5) | -2.67 (0.94) | |
| E3 Ubiquitin Protein Ligase | Mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome | 1.65 (0.76) | ||
| Tumor Protein P53 Inducible Nuclear Protein 2 | Dual regulator of transcription and autophagy | |||
| Cyclin-Dependent Kinase Inhibitor 1A | Functions as a regulator of cell cycle progression | |||
| Cyclin D1 | Regulates the cell-cycle during G(1)/S transition | 0.03 (0.10) | 1.98 (0.79) | |
| Cyclin-Dependent Kinase 3 | Promotes entry into S phase | -1.07 (0.09) | 2.66 (0.66) | |
| Cyclin-Dependent Kinase Inhibitor 2A | Inducing cell cycle arrest in G1 and G2 phases | 1.51 (0.53) | ||
| TSPY-like/SET/nucleosome assembly protein-1 | Chromatin remodeling and as an inhibitor of cell-cycle progression | -1.41 (0.71) | ||
| V-Myb Avian Myeloblastosis Viral Oncogene Homolog-Like 1 | Strong transcriptional activator; involved in the proliferation and/or differentiation | -2.23 (0.56) | ||
| V-Myb Avian Myeloblastosis Viral Oncogene Homolog-Like 2 | Transcription factor involved in the regulation of cell survival, proliferation, and differentiation | -1.42 (0.72) | ||
| Chaperone Heat Shock 70 kDa Protein 8 | Increasing cell survival, repressor of transcriptional activation, participates in the ER-associated degradation | -1.85 (0.66) | -1.48 (0.73) | |
| SET Nuclear Proto-Oncogene | Inhibits acetylation of nucleosomes, especially histone H4, by histone acetylases | -1.56 (0.52) | ||
| Baculoviral inhibition of apoptosis protein repeat Containing 6 | Anti-apoptotic protein which can regulate cell death by controlling caspases | -1.0 (0.13) | ||
| Breast Cancer 2 Tumor Suppressor | Involved in maintenance of genome stability, | - 2.68 (0.74) | ||
| Growth Arrest-Specific 2 | Regulation of microfilament dynamic during both cell cycle and apoptosis | - 3.65 (0.73) | ||
| Breast Cancer 1, Early Onset; E3 ubiquitin-protein ligase | Plays a role in maintaining genomic stability | |||
| BRCA1 Associated RING Domain 1 | Interacts with the BRCA1, involved in DNA repair | - 3.39 (0.76) | ||
| Fanconi Anemia Group M Protein | Key reaction in DNA repair. | -4.25 (0.48) | ||
| Interacting Protein C-Terminal Helicase 1 | DNA-dependent ATPase and 5 to 3 DNA helicase required for the maintenance of chromosomal stability | -2.19 (0.58) | ||
| DNA Helicase, RecQ-Like Type 2 | DNA helicase, ATP dependent, involved in DNA replication and repair. | -2.61(0.76) | ||
| RecQ Mediated Genome Instability 1 | Role in the processing of homologous DNA recombination intermediates | -1.48 (0.41) | ||
| Retinoblastoma-Like 2, cell cycle regulation interacting with E2F-like transcription factor | Key regulator of entry into cell division. Directly involved in heterochromatin formation by maintaining overall chromatin structure | -1.09 (0.16) | ||
| Retinoblastoma-Like 1 | Involved in cell cycle regulation, interacting with transcription factor E2F-4 and with cyclin E/A-CDK2 complexes | -2.09 (0.75) | ||
| Retinoblastoma 1 | Key regulator of entry into cell division, promotes G0-G1 transition | -2.09 (0.75) | ||
| RAS-Like, Family 11, Member A small GTPase | Regulator of rDNA transcription; mediated signal transduction | |||
| Proto-Oncogene C-Myc | Activates the transcription of growth-related genes | -1.15 (0.24) | ||
| Murine Osteosarcoma Viral Oncogene Homolog | Transcription factor involved in signal transduction, cell proliferation and differentiation | |||
| Cysteine-Rich, Anigogenic Inducer, 61 | Promotes cell proliferation, chemotaxis, angiogenesis and cell adhesion | 1.77 (0.62) | ||
| Interleukin 33 chromatin-associated nuclear factor | Acts as a chromatin-associated nuclear factor with transcriptional repressor properties | 2.28 (0.58) | ||
| Four And A Half LIM Domains 2 | Molecular transmitter linking various signaling pathways to transcriptional regulation | 1.58 (0.55) | ||
| Apoptosis Regulator Bcl-X | The longer isoform acts as an apoptotic inhibitor and the shorter form acts as an apoptotic activator. | 1.73 (0.48) | 1.49 (0.71) | |
| Apoptosis Regulator BCL-W BCL2-like 2 | Promotes cell survival, suppressing death-promoting activity of BAX. | 1.03 (0.08) | 1.93 (0.77) | |
| BCL2-Related Protein A1 | Retards apoptosis | 2.27 (0.46) | 2.13 (0.79) | |
| BCL2-Antagonist/Killer 1 | Accelerates programmed cell death by binding to, and antagonizing the anti-apoptotic action of BCL2 | 1.4 (0.40) | 1.78 (0.78) | |
| BH3 Interacting Domain Death Agonist | Induce apoptosis | 1.29 (0.32) | 2.20 (0.92) | |
| Serine/Threonine-Protein Kinase PINK1 | Protect against C2-ceramide-induced CAD cell death through the PI3K/AKT pathway | 1.54 (0.49) | 1.80 (0.78) | |
| Baculoviral IAP Repeat Containing 5 | Inhibitor of apoptosis | 1.04 (0.09) | 1.77 (0.75) | |
| Transmembrane BAX Inhibitor Motif-Containing Protein 3 | Glutamate receptor, potential apoptotic regulator | 1.78 (0.79) | ||
| Peptidylprolyl Isomerase D | Accelerate the folding of proteins, involved in apoptosis | -3.22 (0.78) | ||
| Mitotic Checkpoint Serine/Threonine Kinase B, | Implicated in triggering apoptosis in polyploid cells | -1.69 (0.77) | ||
| RNA Helicase-DEAD Box Protein 116 | Involved in growth inhibition and apoptosis | -1.45 (0.27) | ||
| Apoptosis Enhancing Nuclease | Exonuclease, mediates p53-induced apoptosis | |||
| BCL2-Associated X Protein | Accelerates programmed cell death by binding to, and antagonizing the apoptosis repressor BCL2 | 1.95 (0.66) | ||
| Pleckstrin Homology-Like Domain 3 | Contributes to p53/TP53-dependent apoptosis | 2.01 (0.74) | ||
| Programmed Cell Death Protein 4 | Participate in apoptotic process | -1.23 (0.60) | ||
| Tumor Necrosis Factor Receptor Superfamily, Member 12A | Positive regulation of apoptotic process | -1.27 (0.36) | ||
| Zinc Finger CCCH-Type Containing 12A, | Triggers apoptosis | 1.88 (0.56) | ||
| La Ribonucleoprotein Domain Family, Member 4 | Stimulates mRNA translation | -2.17(0.63) | ||
| La Ribonucleoprotein Domain Family, Member 4B | Stimulates mRNA translation | -2.24 (0.78) | ||
| Eukaryotic Translation Initiation Factor 5 | Catalyzes the hydrolysis of GTP bound to the 40S ribosomal initiation complex | -1.94 (0.56) | ||
| Eukaryotic Translation Initiation Factor 4A2 | ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome | |||
| Sec61 Beta Subunit, | beta-subunit protein of the Sec61 complex (transmembrane channel where proteins are translocated across ER membrane) | 1.58 (0.54) | 2.27 (0.92) | |
| Sec61 Gamma Subunit | gamma—subunit protein of the Sec61 complex (transmembrane channel where proteins are translocated across ER membrane) | 1.69 (0.53) | 1.96 (0.78) | |
| Heat Shock 70kD Protein 5 | Master regulator chaperone | 1.90 (0.68) | -1.08 (0.40) | |
| UDP-Glc:glycoprotein glucosyltransferase | Re-glucosylates single N-glycans near the misfolded part of the protein, providing quality control for protein folding in the ER | -1.53 (0.53) | -2.97 (0.94) | |
| Mannosyl-Oligosaccharide Glucosidase | Exohydrolysis of the non-reducing terminal glucose residues in the mannosyl-oligosaccharide Glc(3)Man(9)GlcNAc(2) | -1.73 (0.60) | -1.47 (0.72) | |
| Calreticulin | Calcium-binding chaperone that promotes folding, oligomeric assembly and quality control in the endoplasmic reticulum (ER) | 1.69 (0.62) | 1.61 (0.76) | |
| Calnexin | Membrane ER chaperone that promotes folding | -1.31 (0.38) | -2.11 (0.92) | |
| Protein Disulfide Isomerase 3 | Catalyzes the rearrangement of -S-S- bonds in proteins. | 1.42 (0.47) | 1.44 (0.72) | |
| Alpha-1,2-Mannosidase IB | Involved in the maturation of Asn-linked oligosaccharides, trim alpha-1,2-linked mannose residues from Man(9)GlcNAc(2) to produce Man(5)GlcNAc(2) | -2.48(0.93) | ||
| Translocon-Associated Protein Gamma Subunit | Part of a complex that regulates the retention of ER resident proteins | -1.47 (0.45) | ||
| Homocysteine-Inducible, ER Stress-Inducible, Ubiquitin-Like Domain Member 1 | Involved in ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins. | 1.32 (0.67) | ||
| Phosphomannomutase 1, D-mannose 6-phosphate | Catalyzing the second step in the conversion of fructose-6P to GDP-mannose | 2.02 (0.74) | ||
| Protein-Cysteine N-Palmitoyltransferase | Key regulator of the Wnt signaling pathway by mediating the attachment of palmitoleate, a 16-carbon monounsaturated fatty acid | 1.61 (0.45) | ||
| Dolichyl-Phosphate Mannosyltransferase Polypeptide 3 | Stabilizer subunit of the dolichol-phosphate mannose (DPM) synthase complex | 1.42 (0.37) | ||
| Fucosyltransferase 1 | Participates in glycosphingolipid biosynthesis | -1.00 (0.07) | ||
| Sialidase 1 | Cleaves terminal sialic acid residues from substrates such as glycoproteins and glycolipids | 1.94 (0.67) | 2.43 (0.93) | |
| Sialidase 2 | Remove sialic acid residues from glycoproteins and glycolipids. | 1.94 (0.67) | ||
| Alpha-L-Fucosidase I | Involved in the degradation of fucose-containing glycoproteins and glycolipids | 1.38 (0.44) | 2.00 (0.92) | |
| Fukutin, Glycosyltransferase | Involved in the biosynthesis of the phosphorylated O-mannosyl trisaccharide | -2.89(0.69) | ||
| Polypeptide N-Acetylgalactosaminyltransferase 1 | Catalyze the transfer of N-acetyl-D-galactosamine to serine and threonine residues | -1.43(0.41) | -2.178 (0.93) | |
| Polypeptide N-Acetylgalactosaminyltransferase 7 | Catalyze the transfer of N-acetyl-D-galactosamine to serine and threonine residues | -1.68 (0.52) | -2.48 (0.93) | |
| Polypeptide N-Acetylgalactosaminyltransferase 13 | Catalyze the transfer of N-acetyl-D-galactosamine to serine and threonine residues | -3.33 (0.33) | -2.55 (0.71) | |
| UDP-N-Acetylglucosamine (UDP-GlcNAc) Transporter | Supply UDP-GlcNAc as substrate for Golgi-resident glycosyltransferases that generate branching of diantennary oligosaccharides. | -1.17 (0.18) | ||
| Lactate dehydrogenase A | Glycolysis, energy pathway | |||
| Lactate Dehydrogenase C | Glycolysis, energy pathway | |||
| Glyceraldehyde-3-Phosphate Dehydrogenase | Role in glycolysis and nuclear functions | -1.02 (0.09) | 1.00 (0.21) | |
| Hexokinase 1 | Glycolysis and gluconeogenesis, energy pathway | 1.01 (0.09) | 1.10 (0.44) | |
| Lactase | Lactase activity | -1.49 (0.73) | ||
| Glutaminase | Catalyzes the hydrolysis of glutamine to glutamate and ammonia | 1.52 (0.30) | ||
| Solute Carrier Family 1 (Glutamate Transporter), 7 | Transports L-glutamate | -1.12 (0.19) | 1.83 (0.79) | |
| Phosphopantothenoylcysteine Decarboxylase | Biosynthesis of coenzyme A (CoA) from pantothenic acid (vitamin B5) | |||
| Phosphoglycolate Phosphatase | Phosphoglycolate phosphatase activity | -1.03 (0.10) | ||
| Galactokinase 1 | Major enzyme for galactose metabolism | -1.10 (0.18) | ||
| NADH Dehydrogenase (Ubiquinone) 1 Beta Subcomplex, 7 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | 1.49 (0.44) | ||
| NADH Dehydrogenase (Ubiquinone) Fe-S Protein 7 | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | -1.07 (0.15) | ||
| Carbonyl Reductase 2 | Carbonyl reductase | 1.87 (0.41) | ||
| Carbonyl Reductase 3 | Carbonyl reductase | 1.70 (0.42) | ||
| Glutathione S-Transferase Pi 1 | Conjugation of reduced glutathione to a exogenous and endogenous hydrophobic electrophiles | 1.00 (0.21) | 1.02 (0.54) | |
Fig 4Pictorial representation of transcripts expressed differentially in response to moderate hypothermia after 24 or 48 h of exposition.
Differentially expressed genes after 24 h of TDS, up regulated genes are presented in orange; down regulated genes are presented in blue. Differentially expressed genes after 48 h of TDS, up regulated genes are presented in red; down regulated genes are presented in green. Black arrows and red lines represent stimulation and inhibition, respectively.